G Heydari
Overview
Explore the profile of G Heydari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aryanpur M, Masjedi M, Hosseini M, Mortaz E, Tabarsi P, Soori H, et al.
Int J Tuberc Lung Dis
. 2016 Apr;
20(5):679-84.
PMID: 27084824
Background: The association between pulmonary tuberculosis (PTB) and tobacco smoke has been verified by most studies on the subject; figures from different countries for the prevalence of smoking among PTB...
2.
Heydari G, Talischi F, Batmanghelidj E, Pajooh M, Boroomand A, Zamani M, et al.
East Mediterr Health J
. 2014 Jul;
19 Suppl 3:S25-31.
PMID: 24995756
This parallel, randomized, open-ended clinical trial tested the impact of nicotine replacement pharmacotherapy during the course of methadone treatment among opiate abusers. A total of 424 men entered the study...
3.
Heydari G, Ahmady A, Lando H, Almasinia B
East Mediterr Health J
. 2014 Jun;
20(5):324-9.
PMID: 24952290
Telephone smoking cessation counselling is a very cost-effective means of reaching dependent smokers in a population. We investigated the frequency of contacts and the types of topics that people accessed...
4.
Heydari G, Talischi F, Mojgani N, Masjedi M, Algouhmani H, Lando H, et al.
East Mediterr Health J
. 2013 Jan;
18(11):1102-6.
PMID: 23301371
The aim of this cross-sectional observational study was to address the health care situation in regard to smoking cessation efforts and expenditure, and to provide a basis for future studies...
5.
Heydari G, Marashian M, Ahmady A, Masjedi M, Lando H
East Mediterr Health J
. 2013 Jan;
18(10):1005-10.
PMID: 23301354
Nicotine replacement therapy can double the chance of success for smokers attempting to quit. This observational study aimed to compare quit rates of different formulations of nicotine replacement among clients...
6.
Heydari G, Talischi F, Masjedi M, Alguomani H, Joossens L, Ghafari M
East Mediterr Health J
. 2012 Oct;
18(8):803-10.
PMID: 23057368
This cross-sectional survey aimed to provide an overview of tobacco control strategies in the countries of the Eastern Mediterranean Region (EMR). A questionnaire to collate data on implementation of 6...
7.
Saber E, Heydari G
Comput Biol Med
. 2012 Mar;
42(5):631-8.
PMID: 22445097
The velocity field and deposition fraction of the particles in the trachea and the first third generations of tracheobronchial tree are investigated with CFD simulation. The air flow rate of...
8.
Heydari G, Talischi F, Tafti S, Masjedi M
Int J Tuberc Lung Dis
. 2012 Jan;
16(2):268-72.
PMID: 22236931
Background: Smoking cessation programmes were first introduced in Iran in 1997. To date a number of types of nicotine replacement therapy have been prescribed. Objective: To evaluate the effectiveness of...
9.
Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, Movahedi M, Parvaneh N, Pouladi N, et al.
J Investig Allergol Clin Immunol
. 2009 May;
19(2):139-45.
PMID: 19476018
Intravenous immunoglobulin (IVIG) replacement therapy improves health-related quality of life in patients with a primary immunodeficiency disease, although there have been reports of adverse reactions associated with its regular administration....
10.
Heydari G, Sharifi H, Hosseini M, Masjedi M
East Mediterr Health J
. 2008 Feb;
13(5):1017-21.
PMID: 18290393
This study in 2003 determined the prevalence of smoking and its associated factors among high-school students in Tehran, Islamic Republic of Iran. Out of 1095 students aged 14-18 years, 29%...